IFNA1 and adult T-cell leukemia/lymphoma: The combination of AZT (azidothymidine) and IFN-α (alpha-interferon) was initially proposed by Gill et al.[27] and Hermine et al. [28] and is currently recognized as one of the most effective therapies for ATLL [7].